Showing results (11-20 of 36) with videos related to
Sort By:
Pageof 4
Life Sciences|May 26, 1998
Comparison of D2 and D3 dopamine receptor affinity of dopaminergic compounds in rat brainR J Flietstra, B LevantEuropean Journal of Pharmacology|June 20, 1989
Effects of anticholinergic drugs on regional brain neurotensin concentrationsB Levant, G Bissette, C B NemeroffGlia|January 7, 1998
Activated astrocytes induce nitric oxide synthase-2 in cerebral endothelium via tumor necrosis factor alphaR A Shafer, S MurphyThe Journal of Pharmacology and Experimental Therapeutics|February 1, 1993
[3H]quinpirole binding to putative D2 and D3 dopamine receptors in rat brain and pituitary gland: a quantitative autoradiographic studyB Levant, D E Grigoriadis, E B DeSouzaBrain Research|November 14, 1998
Alterations in local cerebral glucose utilization produced by D3 dopamine receptor-selective doses of 7-OH-DPAT and nafadotrideB Levant, R S Cross, T L PazdernikEuropean Journal of Pharmacology|April 14, 2000
Pharmacology of quinpirole-stimulated [35S]GTPgammaS binding: discrepancy with receptor binding profileS L Gilliland, R H Alper, B LevantSynapse (New York, N.Y.)|September 1, 1996
In vivo occupancy of D2 dopamine receptors by 7-OH-DPATB Levant, G N Bancroft, C M SelkirkThe Journal of Pharmacology and Experimental Therapeutics|September 1, 1992
Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brainB Levant, D E Grigoriadis, E B DeSouzaEuropean Journal of Pharmacology|July 15, 1993
Monoamine oxidase inhibitors inhibit [3H]quinpirole binding in rat striatal membranesB Levant, D E Grigoriadis, E B DeSouzaRegulatory Peptides|February 1, 1991
Alterations in regional brain neurotensin concentrations produced by atypical antipsychotic drugsB Levant, G Bissette, E Widerlöv, et al.Pageof 4